RPI-1 Catalog No.:M16910-C Consequences of Dispersity on the

Consequences of Dispersity on the Self-Assembly of ABA-Type Amphiphilic Block Co-Oligomers

and filaggrin (5

Losartan is an angiotensin II receptor antagonist

covalent inhibitor of phosphoinositide 3-kinases (PI3Ks) and Polo-Like kinase 1 (PLK1)

LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB

RPI-1 Catalog No.:M16910-C Consequences of Dispersity on theRPI 1 is a specific, orally available 2 indolinone Ret tyrosine kinase inhibitor. RPI 1 inhibits proliferation, Ret tyrosine phosphorylation, Ret protein expression, and the activation of PLCgamma, ERKs and AKT in human medullary thyroid carcinoma TT cells. Antitumor activity. Product information CAS Number: 269730 03 2 Molecular Weight: 297. 31 Formula: C17H15NO4 Chemical Name: (3Z) 3 [(4 hydroxyphenyl)methylidene] 5,6 dimethoxy 2,3 dihydro 1H indol